RCN3 and glioblastoma: RCN3 expression may be an important diagnostic and prognostic factor, and glioblastoma patients with high RCN3 expression may exhibit poor survival rates compared to low RCN3 expression group; thus, RCN3 will serve as a valuable therapeutic target for patients with glioblastoma.